DOAC

ESC 22: 3 Trials That Will Change Your Practice With Dr Afzal Sohaib

Afzal Sohaib,

Watch time: 3:29
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan,

Watch time: 17:13
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24:27
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

HRS 21: Results from the STROKE-VT Trial

Dhanunjaya Lakkireddy,

AF Symposium 2021 Summary: Pill-in-the-Pocket Anticoagulation for AF

Rod S Passman,

George D Katritsis , Demosthenes G Katritsis ,

Pascal Vranckx , Marco Valgimigli , Hein Heidbuchel ,

Andreas Goette , Hein Heidbuchel ,

Philipp Bushoven , Sven Linzbach , Mate Vamos , et al

ESC 2020: Edoxaban for Elderly AF Patients — Dr Ken Okumura

Ken Okumura,

Wern Yew Ding , Dhiraj Gupta ,

Andreas Goette , Hein Heidbuchel ,

Georg Nickenig, Todd Villines, Christopher P Cannon, et al

Pascal Vranckx , Marco Valgimigli , Hein Heidbuchel ,

Philipp Bushoven , Sven Linzbach , Mate Vamos , et al

AF Symposium 2021 Summary: Pill-in-the-Pocket Anticoagulation for AF

Rod S Passman,

George D Katritsis , Demosthenes G Katritsis ,

View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24:27

Gheorghe-Andrei Dan,

ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

Wern Yew Ding , Dhiraj Gupta ,

ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan,

Watch time: 17:13
HRS 21: Results from the STROKE-VT Trial

Dhanunjaya Lakkireddy,

Media

ESC 22: 3 Trials That Will Change Your Practice With Dr Afzal Sohaib

Afzal Sohaib,

Watch time: 3:29
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan,

Watch time: 17:13
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24:27
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

HRS 21: Results from the STROKE-VT Trial

Dhanunjaya Lakkireddy,

AF Symposium 2021 Summary: Pill-in-the-Pocket Anticoagulation for AF

Rod S Passman,

ESC 2020: Edoxaban for Elderly AF Patients — Dr Ken Okumura

Ken Okumura,

HRS 2020: Incidence of Silent Brain Infarcts in Anticoagulated Patients with AF

Georg Nickenig, Todd Villines, Christopher P Cannon, et al

Gheorghe-Andrei Dan,

A John Camm, Paulus Kirchhof, Raffaele De Caterina, et al

Articles

Complications in Anticoagulated Patients with AF

George D Katritsis

,

Demosthenes G Katritsis

,

Citation:

Arrhythmia & Electrophysiology Review 2017;6(4):167–78.

DOI:

https://doi.org/10.15420/aer.2017.23.1
  • Views: Views 1161
  • Downloads: Downloads 18

Drug–Drug and Drug–Food Interactions of Oral Anticoagulation

Pascal Vranckx

,

Marco Valgimigli

,

Hein Heidbuchel

,

Citation:

Arrhythmia & Electrophysiology Review 2018;7(1):55–61.

DOI:

https://doi.org/10.15420/aer.2017.50.1
  • Views: Views 4376
  • Downloads: Downloads 37

Anticoagulation Strategy in Atrial Fibrillation Cardioversion

Andreas Goette

,

Hein Heidbuchel

,

Citation:

Arrhythmia & Electrophysiology Review 2017;6(2):50–4.

DOI:

https://doi.org/10.15420/aer.2017:3:2
  • Views: Views 9610
  • Downloads: Downloads 37

Optimal Anticoagulation Strategy for Cardioversion in Atrial Fibrillation

Philipp Bushoven

,

Sven Linzbach

,

Mate Vamos

,

Stefan H Hohnloser

,

Citation:

Arrhythmia & Electrophysiology Review 2015;4(1):44-6

DOI:

https://doi.org/10.15420/aer.2015.4.1.44
  • Views: Views 1777
  • Downloads: Downloads 3